Train, Babcock Advisors »

SPDR S&P Biotech shares owned by Train, Babcock Advisors

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Train, Babcock Advisors from 13F filings

Historical chart of Train, Babcock Advisors investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Train, Babcock Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Train, Babcock Advisors

Quarter filed Position value Share count Share price at filing
2017-12-31 $815k 9.6k 84.91
2017-06-30 $690k 8.9k 77.22

More positions owned by Train, Babcock Advisors

Spdr S&p 500 Etf (SPY)
Apple (AAPL)
Accenture (ACN)
Vantiv Inc Cl A
PowerShares QQQ Trust, Series 1
UnitedHealth (UNH)
Alphabet Inc Class C cs (GOOG)
Masco Corporation (MAS)
CHECK POINT SOFTWARE Technolog Com Stk (CHKP)
Nike (NKE)
Zoetis Inc Cl A (ZTS)
Verizon Communications (VZ)
Arthur J. Gallagher & Co. (AJG)
Alerian Mlp Etf
Visa (V)

View all positions for Train, Babcock Advisors

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Citadel Advisors
Millennium Management
UBS Group
Bank of America Corporation
Citigroup
venBio Select Advisor
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Nantahala Capital Management
Healthcare Of Ontario Pension Plan Trust Fund
Moore Capital Management
Barclays
Perceptive Advisors
Gts Securities

View all funds holding SPDR S&P Biotech